Coeptis Therapeutics Holdings, Inc. - PE Ratio

The PE Ratio as of August 2026 (TTM) for Coeptis Therapeutics Holdings, Inc. (COEP) is -3.91

According to Coeptis Therapeutics Holdings, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.91. This represents a change of -27.85% compared to the average of -5.42 of the last 4 quarters.

Coeptis Therapeutics Holdings, Inc. (COEP) Historical PE Ratio (quarterly & annually)

How has COEP PE Ratio performed in the past?

The mean historical PE Ratio of Coeptis Therapeutics Holdings, Inc. over the last ten years is -1.05. The current -3.91 PE Ratio has changed 37.28% with respect to the historical average. Over the past ten years (40 quarters), COEP's PE Ratio was at its highest in in the June 2020 quarter at 3.35K. The PE Ratio was at its lowest in in the December 2025 quarter at -9.93.

Coeptis Therapeutics Holdings, Inc. (COEP) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Coeptis Therapeutics Holdings, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Coeptis Therapeutics Holdings, Inc. (COEP) Average PE Ratio

How has COEP PE Ratio performed in the past?

The current PE Ratio of Coeptis Therapeutics Holdings, Inc. (COEP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Coeptis Therapeutics Holdings, Inc. (COEP) PE Ratio vs. Peers

How is COEP’s PE Ratio compared to its peers?

Coeptis Therapeutics Holdings, Inc.’s PE Ratio is greater than Equillium, Inc. (-5.82), less than Century Therapeutics, Inc. (-1.57), greater than Cue Biopharma, Inc. (-4.83), less than NRx Pharmaceuticals, Inc. (-2.38), less than Karyopharm Therapeutics Inc. (-0.13), less than Outlook Therapeutics, Inc. (-0.75), less than Medicus Pharma Ltd. Common Stock (-0.13), less than OS Therapies Incorporated (-1.50), less than Senti Biosciences, Inc. (-0.19), greater than Telomir Pharmaceuticals, Inc. Common Stock (-4.01),

Build a custom stock screener for Coeptis Therapeutics Holdings, Inc. (COEP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Coeptis Therapeutics Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Coeptis Therapeutics Holdings, Inc. (COEP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Coeptis Therapeutics Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.